URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Charles Francis

Concepts (717)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Anticoagulants
32
1984
141
8.880
Why?
Fibrin
48
1979
85
8.140
Why?
Fibrinogen
49
1979
149
7.420
Why?
Thrombosis
33
1984
196
6.560
Why?
Venous Thrombosis
20
2000
80
4.960
Why?
Fibroblast Growth Factor 2
13
1998
85
4.710
Why?
Endothelium, Vascular
21
1989
454
4.290
Why?
Heparin
17
1985
124
3.920
Why?
Fibrinolysis
28
1981
44
3.900
Why?
Warfarin
17
1983
49
3.680
Why?
Venous Thromboembolism
10
2007
28
3.350
Why?
Thrombolytic Therapy
17
1991
64
3.300
Why?
Thrombophlebitis
20
1979
42
3.220
Why?
Thromboembolism
11
1986
43
3.100
Why?
Fibrinolytic Agents
20
1979
60
3.070
Why?
Thrombin
15
1983
150
2.750
Why?
Neoplasms
14
1993
743
2.510
Why?
Ultrasonics
9
1992
108
2.480
Why?
Blood Platelets
18
1983
281
2.440
Why?
Ultrasonic Therapy
9
1993
29
2.410
Why?
Fibrin Fibrinogen Degradation Products
23
1980
48
2.330
Why?
Thrombocytopenia
5
1999
77
2.290
Why?
Azetidines
7
2001
8
2.260
Why?
Humans
205
1979
37165
2.230
Why?
Tissue Plasminogen Activator
19
1989
50
2.040
Why?
Fibrinolysin
21
1980
34
1.870
Why?
Arthroplasty, Replacement, Knee
7
1998
21
1.810
Why?
Postoperative Complications
14
1983
764
1.780
Why?
Hip Prosthesis
9
1986
40
1.610
Why?
Evidence-Based Medicine
6
2009
210
1.450
Why?
Heparin, Low-Molecular-Weight
7
2001
16
1.370
Why?
Middle Aged
64
1983
10013
1.280
Why?
Societies, Medical
4
1993
142
1.220
Why?
Male
74
1983
20139
1.210
Why?
Aged
54
1983
7392
1.210
Why?
Umbilical Veins
12
1990
80
1.200
Why?
Streptokinase
14
1984
32
1.200
Why?
Hemorrhage
14
1983
181
1.150
Why?
Enoxaparin
5
2001
8
1.090
Why?
Knee Prosthesis
6
1988
12
1.060
Why?
Integrin alphaVbeta3
2
2004
7
1.050
Why?
Pulmonary Embolism
11
1985
59
1.020
Why?
Plasminogen Activator Inhibitor 1
3
1997
38
1.010
Why?
Thiazolidinediones
4
2004
76
1.000
Why?
Female
67
1983
20222
1.000
Why?
Hospital Mortality
4
2006
137
0.990
Why?
Nitric Oxide Synthase
3
2002
163
0.980
Why?
Polymorphism, Genetic
3
2002
200
0.950
Why?
Platelet Transfusion
4
2008
86
0.930
Why?
Interleukin-1
2
2004
221
0.930
Why?
Arthroplasty, Replacement, Hip
6
1998
46
0.890
Why?
Aspirin
3
1986
59
0.880
Why?
Urokinase-Type Plasminogen Activator
13
1979
63
0.880
Why?
Cells, Cultured
18
1987
2589
0.880
Why?
Megakaryocytes
7
1989
67
0.860
Why?
Protein Binding
14
1986
867
0.860
Why?
Prospective Studies
25
1983
1696
0.850
Why?
Primary Prevention
2
2009
61
0.850
Why?
Hospitalization
4
2001
385
0.840
Why?
Fibrinopeptide B
7
1984
11
0.840
Why?
Antithrombin III
6
1986
14
0.830
Why?
Ischemia
3
1994
91
0.820
Why?
Vascular Endothelial Growth Factor A
5
2000
212
0.820
Why?
Disseminated Intravascular Coagulation
4
1979
15
0.810
Why?
Hypoglycemic Agents
2
2004
107
0.800
Why?
Blood Coagulation
10
1980
74
0.800
Why?
Myocardial Infarction
13
1984
651
0.780
Why?
Factor XIII
3
1987
6
0.770
Why?
Coronary Vessels
5
1985
133
0.770
Why?
Diabetes Mellitus
1
2012
168
0.770
Why?
Administration, Oral
10
1993
314
0.760
Why?
Cell Division
7
1995
773
0.760
Why?
Phlebography
11
1989
33
0.760
Why?
Neovascularization, Physiologic
4
1998
129
0.750
Why?
Nitric Oxide
4
2002
255
0.720
Why?
Information Dissemination
1
2009
24
0.700
Why?
NF-kappa B
4
2003
434
0.680
Why?
Risk Assessment
8
2005
875
0.670
Why?
Cause of Death
1
2009
158
0.670
Why?
Publishing
1
2009
45
0.670
Why?
Treatment Outcome
14
1992
2671
0.660
Why?
Hospitals
1
2009
67
0.650
Why?
Antineoplastic Agents
4
2006
628
0.650
Why?
Aryl Hydrocarbon Hydroxylases
1
2008
24
0.640
Why?
Enzyme-Linked Immunosorbent Assay
10
1986
472
0.630
Why?
Internet
1
2009
106
0.630
Why?
Periodicals as Topic
1
2009
79
0.620
Why?
von Willebrand Factor
9
1980
67
0.610
Why?
Randomized Controlled Trials as Topic
9
1989
415
0.600
Why?
Platelet Adhesiveness
4
1992
12
0.600
Why?
Plasma
3
1983
33
0.590
Why?
Dose-Response Relationship, Drug
12
1983
1142
0.590
Why?
Animals
25
1986
16416
0.580
Why?
Electrophoresis, Polyacrylamide Gel
21
1979
387
0.580
Why?
Peptide Fragments
10
1983
307
0.580
Why?
Arterial Occlusive Diseases
4
1984
51
0.580
Why?
Femoral Artery
4
1984
75
0.570
Why?
Adult
38
1984
11572
0.570
Why?
Benzylamines
7
2001
16
0.570
Why?
Practice Guidelines as Topic
5
2002
319
0.550
Why?
Hemostasis
6
1987
61
0.550
Why?
Receptors, Fibrinogen
1
2005
1
0.550
Why?
Leg
3
1993
99
0.550
Why?
Biological Assay
3
1999
69
0.540
Why?
Superior Vena Cava Syndrome
1
2005
7
0.540
Why?
Survival Analysis
6
2005
589
0.530
Why?
Lymphoma, B-Cell
1
2006
66
0.530
Why?
Plasma Exchange
3
1985
18
0.520
Why?
Lymphoma, Large B-Cell, Diffuse
1
2006
80
0.520
Why?
Drug Administration Schedule
9
1987
374
0.520
Why?
Vascular Diseases
4
1989
74
0.520
Why?
Fibrinopeptide A
7
1984
16
0.520
Why?
Benzimidazoles
3
2008
23
0.510
Why?
Blood Transfusion
2
2001
171
0.510
Why?
Dalteparin
3
1997
5
0.510
Why?
Receptors, Fibroblast Growth Factor
1
2004
9
0.500
Why?
Recombinant Proteins
12
1989
770
0.500
Why?
Endothelial Cells
2
2004
211
0.500
Why?
Plasminogen
12
1981
24
0.500
Why?
Macromolecular Substances
18
1980
216
0.490
Why?
Binding Sites
7
1996
742
0.480
Why?
Double-Blind Method
11
1990
996
0.480
Why?
Dextrans
6
1983
43
0.480
Why?
Time Factors
19
1982
3234
0.480
Why?
Pyridines
3
2008
85
0.480
Why?
Prodrugs
4
2001
21
0.470
Why?
Receptor Protein-Tyrosine Kinases
1
2004
81
0.470
Why?
Chemokines
1
2004
112
0.470
Why?
Thromboplastin
3
2007
74
0.470
Why?
Atrial Fibrillation
1
2005
112
0.460
Why?
Myocardial Ischemia
1
2004
120
0.460
Why?
Coronary Thrombosis
2
1993
10
0.460
Why?
Risk Factors
14
1993
2331
0.460
Why?
Clinical Trials as Topic
7
1983
685
0.450
Why?
Ultrasonography, Doppler, Duplex
1
2003
22
0.450
Why?
Pacemaker, Artificial
1
2005
163
0.450
Why?
Receptors, Cell Surface
1
2004
217
0.440
Why?
Aortic Aneurysm, Abdominal
2
1997
29
0.440
Why?
Genetic Variation
4
1980
147
0.440
Why?
Aged, 80 and over
11
1997
2588
0.440
Why?
Models, Biological
1
2008
1029
0.430
Why?
Prognosis
6
1986
1078
0.430
Why?
Blood Coagulation Disorders
3
1985
37
0.420
Why?
Molecular Weight
19
1979
372
0.410
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2001
14
0.400
Why?
Purpura
1
2001
18
0.400
Why?
Polymers
4
1983
84
0.400
Why?
Retrospective Studies
10
1992
2302
0.400
Why?
Isoantibodies
1
2001
58
0.390
Why?
Magnetic Resonance Angiography
2
1995
38
0.390
Why?
Defibrillators, Implantable
1
2005
377
0.380
Why?
Endothelial Growth Factors
1
2000
82
0.370
Why?
Lymphokines
1
2000
119
0.370
Why?
Terminology as Topic
3
1987
108
0.360
Why?
Drug Synergism
2
2007
163
0.360
Why?
International Normalized Ratio
1
1999
8
0.360
Why?
Amino Acid Sequence
12
1986
1227
0.350
Why?
Prostaglandin D2
3
2004
64
0.350
Why?
Combined Modality Therapy
7
1987
491
0.350
Why?
Cell Proliferation
4
2004
520
0.340
Why?
Thrombopoiesis
2
2008
15
0.340
Why?
Status Epilepticus
1
1998
9
0.330
Why?
Gene Expression Regulation
1
2004
895
0.330
Why?
Purpura, Thrombotic Thrombocytopenic
3
1985
11
0.330
Why?
Hemophilia A
2
2004
38
0.330
Why?
Thrombophilia
3
2001
12
0.320
Why?
Factor V
1
1998
23
0.320
Why?
Random Allocation
8
1983
253
0.320
Why?
Platelet Aggregation
5
1983
64
0.320
Why?
Premedication
1
1997
21
0.310
Why?
Iodine Radioisotopes
4
1993
104
0.310
Why?
Inpatients
3
2000
69
0.310
Why?
Molecular Sequence Data
11
1988
2046
0.310
Why?
PPAR gamma
3
2006
104
0.310
Why?
Meta-Analysis as Topic
1
1997
36
0.300
Why?
Multiple Organ Failure
1
1997
37
0.300
Why?
Pancreatic Neoplasms
2
2007
84
0.300
Why?
Anemia, Sickle Cell
1
1997
48
0.300
Why?
Point Mutation
1
1998
178
0.290
Why?
Aorta, Thoracic
1
1997
71
0.290
Why?
Cell Adhesion
6
1992
270
0.290
Why?
African Continental Ancestry Group
1
1997
125
0.280
Why?
Rabbits
5
1986
720
0.280
Why?
Kinetics
7
1984
1471
0.280
Why?
Cohort Studies
6
1997
984
0.280
Why?
Antihypertensive Agents
1
1997
83
0.280
Why?
Catheterization, Central Venous
1
1997
56
0.280
Why?
Follow-Up Studies
7
1988
1889
0.270
Why?
Contrast Media
4
1992
269
0.270
Why?
Outcome Assessment (Health Care)
3
1997
301
0.270
Why?
Antibodies, Monoclonal
7
1989
748
0.270
Why?
Coronary Artery Disease
2
2005
88
0.260
Why?
Erythrocyte Transfusion
2
1997
58
0.260
Why?
Predictive Value of Tests
3
2001
609
0.260
Why?
Constriction, Pathologic
2
2004
77
0.260
Why?
Incidence
5
1993
682
0.250
Why?
Ear, External
1
1994
25
0.250
Why?
Orthopedic Procedures
2
2012
46
0.250
Why?
Blood Platelet Disorders
1
1994
7
0.250
Why?
Splenectomy
2
1985
39
0.250
Why?
Contusions
1
1994
22
0.250
Why?
Microscopy, Electron, Scanning
4
1994
120
0.250
Why?
Angioplasty, Balloon, Coronary
1
1994
64
0.240
Why?
Rocky Mountain Spotted Fever
2
2003
7
0.240
Why?
Fibroblast Growth Factor 1
2
2003
14
0.240
Why?
Nitric Oxide Synthase Type III
2
2002
73
0.240
Why?
Hypertension
1
1997
307
0.230
Why?
Inflammation
3
1993
544
0.230
Why?
Blood Coagulation Tests
3
1988
40
0.230
Why?
Chemokine CCL2
2
2004
128
0.230
Why?
Blood
2
1990
96
0.230
Why?
Electrophoresis, Agar Gel
10
1985
42
0.220
Why?
Prothrombin Time
3
1985
19
0.220
Why?
Case-Control Studies
3
2001
624
0.220
Why?
Injections, Subcutaneous
7
1986
93
0.220
Why?
Gravity Suits
1
1992
2
0.220
Why?
Drug Monitoring
1
1992
41
0.220
Why?
Prostatic Neoplasms
2
2007
540
0.220
Why?
Hemostatics
2
2001
21
0.220
Why?
Thymidine
2
2000
89
0.210
Why?
Klebsiella pneumoniae
1
2012
2
0.210
Why?
Klebsiella Infections
1
2012
4
0.210
Why?
Carbapenems
1
2012
2
0.210
Why?
beta-Lactam Resistance
1
2012
6
0.210
Why?
Platelet Function Tests
1
2012
14
0.210
Why?
Seasons
2
2001
91
0.210
Why?
Hemophilia B
1
2011
13
0.210
Why?
Regional Blood Flow
3
1993
186
0.210
Why?
Rare Diseases
1
2011
28
0.200
Why?
Swine
2
1998
182
0.200
Why?
Biological Markers
6
1992
564
0.200
Why?
Up-Regulation
2
2002
375
0.200
Why?
Angioedema
1
1991
8
0.200
Why?
Cross Infection
1
2012
85
0.200
Why?
Dose-Response Relationship, Radiation
2
1998
216
0.200
Why?
Postoperative Hemorrhage
1
2011
19
0.200
Why?
Blood Grouping and Crossmatching
1
2011
32
0.200
Why?
Disease Outbreaks
1
2012
115
0.200
Why?
Respiratory Tract Infections
2
2001
133
0.190
Why?
Coronary Disease
2
1984
257
0.190
Why?
Leukocytosis
1
2010
21
0.190
Why?
ABO Blood-Group System
1
2011
66
0.190
Why?
Plasminogen Activators
6
1982
32
0.190
Why?
Biological Transport
3
1995
399
0.190
Why?
Platelet Activation
2
2006
53
0.190
Why?
Protein C Deficiency
1
1990
5
0.190
Why?
Risk
3
1986
355
0.190
Why?
Calciphylaxis
1
1990
6
0.190
Why?
Trypsin
4
1980
98
0.180
Why?
Cooperative Behavior
1
2011
101
0.180
Why?
alpha-2-Antiplasmin
4
1984
6
0.180
Why?
Bone Cements
2
1986
15
0.180
Why?
C-Reactive Protein
2
2001
117
0.180
Why?
Neovascularization, Pathologic
2
2007
100
0.180
Why?
Lung Neoplasms
3
1987
435
0.180
Why?
Calcinosis
1
1990
62
0.180
Why?
Analysis of Variance
4
1994
749
0.180
Why?
Severity of Illness Index
3
2005
943
0.180
Why?
Blotting, Western
5
1989
672
0.180
Why?
Prostatic Intraepithelial Neoplasia
1
2009
6
0.180
Why?
Length of Stay
1
2011
295
0.180
Why?
Microscopy, Fluorescence
2
1995
277
0.170
Why?
Biomedical Research
1
2011
137
0.170
Why?
Liver
3
1989
884
0.170
Why?
Tissue Array Analysis
1
2009
36
0.170
Why?
Blood Preservation
1
2009
24
0.170
Why?
Fertilization in Vitro
1
2009
32
0.170
Why?
Forkhead Transcription Factors
1
2009
55
0.170
Why?
Drug Therapy, Combination
6
1986
397
0.170
Why?
Cattle
2
1995
560
0.170
Why?
Kidney Failure, Chronic
1
1990
119
0.170
Why?
Proteome
1
2009
53
0.170
Why?
Magnetic Resonance Spectroscopy
1
1990
242
0.160
Why?
Proteomics
1
2009
71
0.160
Why?
Heme Oxygenase-1
1
2008
51
0.160
Why?
Anemia
1
2008
78
0.160
Why?
Binding, Competitive
2
1989
210
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
3
1987
436
0.160
Why?
Rodenticides
1
2008
1
0.160
Why?
Pharmacogenetics
1
2008
10
0.160
Why?
Transport Vesicles
1
2008
7
0.160
Why?
Logistic Models
2
2006
626
0.160
Why?
Estradiol
1
2009
201
0.160
Why?
Retinoid X Receptors
1
2008
28
0.160
Why?
Thiophenes
1
2008
18
0.160
Why?
Morpholines
1
2008
43
0.160
Why?
Mixed Function Oxygenases
1
2008
69
0.160
Why?
Chromogenic Compounds
2
1985
3
0.150
Why?
Rickettsia rickettsii
2
2003
10
0.150
Why?
Dogs
2
1986
492
0.150
Why?
Anti-Bacterial Agents
1
2012
442
0.150
Why?
Chemoprevention
1
2007
12
0.150
Why?
Diagnosis, Computer-Assisted
1
2008
65
0.150
Why?
Apoptosis
2
2003
855
0.150
Why?
Iliac Aneurysm
1
2007
5
0.150
Why?
Skin
1
1990
384
0.150
Why?
Polysaccharides
1
2007
41
0.150
Why?
Carcinoma
1
2009
194
0.150
Why?
Acute Disease
5
1992
591
0.150
Why?
Postprandial Period
1
2007
34
0.150
Why?
Hyperlipidemias
1
2007
46
0.150
Why?
Fasting
1
2007
86
0.150
Why?
Walking
1
2007
42
0.150
Why?
Genotype
3
1998
473
0.150
Why?
Blood Vessel Prosthesis
1
2007
31
0.150
Why?
Gene Expression Regulation, Enzymologic
1
2008
193
0.150
Why?
Blood Vessel Prosthesis Implantation
1
2007
52
0.150
Why?
Gels
2
1995
49
0.150
Why?
Muscle, Skeletal
2
2000
439
0.140
Why?
Eicosanoids
1
2006
16
0.140
Why?
History, 20th Century
1
2008
245
0.140
Why?
Age Factors
5
1986
1152
0.140
Why?
RNA, Small Interfering
1
2007
208
0.140
Why?
Diabetes Mellitus, Type 2
1
2009
222
0.140
Why?
RNA, Messenger
4
2004
1893
0.140
Why?
Survival Rate
2
2005
619
0.140
Why?
Perfusion
2
1994
134
0.140
Why?
Chorioallantoic Membrane
1
2005
3
0.140
Why?
Stroke
2
2002
138
0.140
Why?
Peptide Hydrolases
1
1986
67
0.140
Why?
Receptors, Interleukin-1
1
2005
9
0.140
Why?
Preoperative Care
3
1983
137
0.140
Why?
Recurrence
5
1992
697
0.130
Why?
Ambulatory Care
1
2007
167
0.130
Why?
Angina, Unstable
1
2005
35
0.130
Why?
Device Removal
1
2005
31
0.130
Why?
Chick Embryo
1
2005
192
0.130
Why?
Angioplasty
1
2005
30
0.130
Why?
Drug Interactions
1
2005
186
0.130
Why?
Neutropenia
1
2006
70
0.130
Why?
Equipment Failure
1
2005
75
0.130
Why?
Tumor Cells, Cultured
1
2007
886
0.130
Why?
Upper Extremity
1
2005
27
0.130
Why?
Capillaries
2
2000
87
0.130
Why?
Receptors, Urokinase Plasminogen Activator
1
2004
9
0.130
Why?
Glycoproteins
3
1981
208
0.130
Why?
Base Sequence
3
1988
1721
0.130
Why?
Ultrasonography
2
1997
257
0.130
Why?
NG-Nitroarginine Methyl Ester
1
2004
41
0.130
Why?
Magnetic Resonance Imaging
4
1989
1019
0.130
Why?
Vitronectin
1
2004
6
0.130
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2004
6
0.130
Why?
Hepatitis C, Chronic
1
2004
18
0.130
Why?
Ultrasonography, Doppler
1
2005
77
0.120
Why?
Leukocytes
1
1986
192
0.120
Why?
Thromboxane B2
1
2004
12
0.120
Why?
Integrins
1
2004
48
0.120
Why?
Prothrombin
2
1993
9
0.120
Why?
Placenta
1
2005
143
0.120
Why?
Sepharose
1
2004
13
0.120
Why?
Hypolipidemic Agents
1
2004
18
0.120
Why?
Immunoprecipitation
1
2004
89
0.120
Why?
Liver Function Tests
1
2004
30
0.120
Why?
Species Specificity
3
1988
342
0.120
Why?
Biopolymers
2
1982
13
0.120
Why?
Interleukin-8
1
2004
111
0.120
Why?
Cell Size
1
2004
96
0.120
Why?
Gene Expression
2
2004
764
0.120
Why?
DNA, Complementary
1
2004
264
0.120
Why?
CD40 Ligand
1
2004
93
0.120
Why?
Lipids
1
2004
166
0.120
Why?
Disease Models, Animal
2
1994
974
0.120
Why?
Protein S
1
2003
10
0.120
Why?
Calcium
2
1996
1135
0.110
Why?
Sex Factors
3
1986
613
0.110
Why?
Blood Coagulation Factors
4
1980
52
0.110
Why?
Patient Selection
2
1997
223
0.110
Why?
Oligopeptides
3
1989
91
0.110
Why?
Mutagenesis
1
2003
142
0.110
Why?
Heart Diseases
1
2004
138
0.110
Why?
Genetic Predisposition to Disease
1
2005
317
0.110
Why?
Aorta
1
2004
198
0.110
Why?
Veins
1
2003
49
0.110
Why?
Guillain-Barre Syndrome
1
2002
5
0.110
Why?
Valine
1
2002
32
0.110
Why?
Receptors, Cytoplasmic and Nuclear
1
2004
135
0.110
Why?
Cross-Linking Reagents
4
1988
87
0.110
Why?
Models, Chemical
1
1983
105
0.110
Why?
United States
6
1993
2847
0.110
Why?
Immunoglobulins, Intravenous
1
2002
37
0.110
Why?
Vasodilation
1
2002
52
0.110
Why?
Ultrasonography, Doppler, Pulsed
1
2002
5
0.110
Why?
Tomography, X-Ray Computed
2
1995
785
0.110
Why?
Enzyme Inhibitors
1
2004
441
0.110
Why?
Chromatography, Agarose
2
1980
7
0.100
Why?
Wound Healing
1
2003
213
0.100
Why?
Mice
4
1997
6206
0.100
Why?
Protein Structure, Tertiary
1
2003
382
0.100
Why?
Probability
3
2005
306
0.100
Why?
Epitopes
3
1989
208
0.100
Why?
Acidosis
1
2002
128
0.100
Why?
Apolipoproteins
1
2001
39
0.100
Why?
Infusions, Parenteral
3
1984
72
0.100
Why?
Vascular Endothelial Growth Factors
1
2000
71
0.100
Why?
Cardiolipins
1
2000
7
0.100
Why?
Odds Ratio
3
2001
323
0.100
Why?
Ultrasonography, Interventional
1
2001
64
0.100
Why?
Chymotrypsin
1
2000
9
0.090
Why?
Anistreplase
4
1986
4
0.090
Why?
Evaluation Studies as Topic
2
1985
247
0.090
Why?
Models, Animal
1
2001
140
0.090
Why?
Osmolar Concentration
1
2000
159
0.090
Why?
Autoantibodies
1
2000
109
0.090
Why?
Hemolysis
2
1997
83
0.090
Why?
Statistics as Topic
2
1994
189
0.090
Why?
Hydrolysis
1
2000
153
0.090
Why?
Multivariate Analysis
3
2001
548
0.090
Why?
Mitochondria
1
2003
346
0.090
Why?
Multicenter Studies as Topic
3
1989
127
0.090
Why?
Immunoassay
1
1999
40
0.090
Why?
Mutation
1
2005
1226
0.090
Why?
Platelet Factor 4
1
1999
23
0.090
Why?
Hot Temperature
1
1979
163
0.090
Why?
Research Design
2
1997
340
0.090
Why?
Bronchi
1
1999
86
0.080
Why?
Trachea
1
1999
70
0.080
Why?
Foreign Bodies
1
1999
49
0.080
Why?
Carcinoma, Small Cell
2
1987
33
0.080
Why?
Chemistry, Physical
1
1998
31
0.080
Why?
Physicochemical Phenomena
1
1998
31
0.080
Why?
Fatal Outcome
1
1998
109
0.080
Why?
Transcription Factors
1
2004
698
0.080
Why?
Microscopy, Confocal
1
1999
196
0.080
Why?
Models, Statistical
2
1996
222
0.080
Why?
Clot Retraction
2
1990
3
0.080
Why?
Blood Loss, Surgical
1
1997
45
0.080
Why?
Sample Size
1
1997
31
0.080
Why?
Confounding Factors (Epidemiology)
1
1997
60
0.080
Why?
Constriction
1
1997
18
0.080
Why?
Influenza, Human
1
2001
345
0.080
Why?
Pressure
1
1997
144
0.080
Why?
Aspartate Aminotransferases
1
1997
36
0.070
Why?
Intraoperative Period
1
1997
46
0.070
Why?
Antifibrinolytic Agents
1
1997
17
0.070
Why?
Convection
1
1996
3
0.070
Why?
Calcium Channel Blockers
1
1997
69
0.070
Why?
L-Lactate Dehydrogenase
1
1997
85
0.070
Why?
Drug Evaluation
2
1984
99
0.070
Why?
Chi-Square Distribution
2
2005
347
0.070
Why?
DNA
2
1995
862
0.070
Why?
Diffusion
1
1996
72
0.070
Why?
Blood Flow Velocity
2
1993
123
0.070
Why?
Surgical Procedures, Elective
2
2001
37
0.070
Why?
Renal Dialysis
2
1984
130
0.070
Why?
Cell Line, Tumor
2
2008
576
0.070
Why?
Reactive Oxygen Species
2
2008
317
0.070
Why?
Young Adult
2
2009
1084
0.070
Why?
Chromatography, Ion Exchange
3
1982
61
0.070
Why?
Hydrostatic Pressure
1
1995
5
0.070
Why?
Thoracoscopy
1
1995
5
0.070
Why?
Pneumothorax
1
1995
23
0.070
Why?
Pleurodesis
1
1995
4
0.070
Why?
Talc
1
1995
5
0.070
Why?
Acrylic Resins
1
1995
38
0.070
Why?
Rheology
1
1995
44
0.060
Why?
Blood Pressure
1
1997
468
0.060
Why?
Batroxobin
2
1986
3
0.060
Why?
Antigens
2
1980
102
0.060
Why?
Myocardial Reperfusion
1
1994
23
0.060
Why?
Platelet Aggregation Inhibitors
2
2003
60
0.060
Why?
Hematology
1
1994
13
0.060
Why?
Arm
1
1994
56
0.060
Why?
Pentetic Acid
1
1994
37
0.060
Why?
Gadolinium DTPA
1
1994
52
0.060
Why?
Postoperative Care
3
1993
130
0.060
Why?
Protein Conformation
4
1981
324
0.060
Why?
Infusions, Intravenous
3
1986
143
0.060
Why?
Organometallic Compounds
1
1994
70
0.060
Why?
Hematocrit
2
1990
111
0.060
Why?
Vascular Surgical Procedures
1
1994
67
0.060
Why?
Amino Acid Chloromethyl Ketones
1
1993
10
0.060
Why?
Rats
3
1988
4389
0.060
Why?
Cell Line
3
1982
1623
0.060
Why?
Serotonin
1
1993
102
0.060
Why?
Transglutaminases
1
1993
65
0.060
Why?
Coronary Angiography
3
1986
83
0.050
Why?
Catheterization
2
1984
124
0.050
Why?
Injections, Intravenous
3
1986
133
0.050
Why?
Diatrizoate Meglumine
1
1992
17
0.050
Why?
Bandages
1
1992
31
0.050
Why?
Ioxaglic Acid
1
1992
5
0.050
Why?
Intermittent Pneumatic Compression Devices
1
2012
3
0.050
Why?
Saudi Arabia
1
2012
4
0.050
Why?
Molecular Typing
1
2012
4
0.050
Why?
Cardiology
1
1993
55
0.050
Why?
Electrophoresis, Gel, Pulsed-Field
1
2012
24
0.050
Why?
Iohexol
1
1992
39
0.050
Why?
Mathematics
2
1984
149
0.050
Why?
Microscopy, Electron
3
1993
395
0.050
Why?
Clinical Protocols
1
1992
107
0.050
Why?
Infection Control
1
2012
22
0.050
Why?
Monitoring, Physiologic
1
1992
110
0.050
Why?
Cluster Analysis
1
2012
90
0.050
Why?
Complement Activation
1
1991
28
0.050
Why?
Blood Component Transfusion
1
2011
21
0.050
Why?
Blood Group Incompatibility
1
2011
37
0.050
Why?
Sensitivity and Specificity
1
1994
914
0.050
Why?
Vascular Patency
2
1990
67
0.050
Why?
Intensive Care Units
1
2012
120
0.050
Why?
Immunoelectrophoresis
1
1990
40
0.050
Why?
Calcimycin
1
1990
55
0.050
Why?
Cell Movement
1
1993
378
0.050
Why?
Bone Marrow
2
1989
292
0.050
Why?
Health Services Accessibility
1
1993
235
0.050
Why?
Popliteal Vein
1
1990
6
0.050
Why?
Nephrotic Syndrome
1
1990
27
0.050
Why?
Leukemia, Megakaryoblastic, Acute
1
2009
10
0.050
Why?
Cell Shape
1
2009
22
0.050
Why?
Nitriles
1
2009
39
0.050
Why?
Femoral Vein
1
1990
13
0.050
Why?
Peptides
2
1979
293
0.050
Why?
Cell Survival
1
1992
559
0.050
Why?
Sulfones
1
2009
25
0.050
Why?
Necrosis
1
1990
103
0.050
Why?
NF-kappa B p50 Subunit
1
2009
35
0.050
Why?
Magnetics
1
1990
37
0.050
Why?
Protein C
1
1990
47
0.040
Why?
Collagen Diseases
1
1989
8
0.040
Why?
alpha-Macroglobulins
1
1989
14
0.040
Why?
Integrin alpha2beta1
1
2009
9
0.040
Why?
Partial Thromboplastin Time
2
1985
13
0.040
Why?
Fetal Blood
1
2009
89
0.040
Why?
Blood Banks
1
2009
12
0.040
Why?
Transcription Factor RelA
1
2009
74
0.040
Why?
Organoplatinum Compounds
1
1989
5
0.040
Why?
Follicle Stimulating Hormone
1
2009
52
0.040
Why?
Structure-Activity Relationship
4
1980
316
0.040
Why?
Mass Spectrometry
1
2009
113
0.040
Why?
Chromatography, High Pressure Liquid
1
2009
209
0.040
Why?
Plethysmography
1
1988
11
0.040
Why?
Venous Insufficiency
1
1988
9
0.040
Why?
Adolescent
3
1986
5044
0.040
Why?
North America
1
2008
29
0.040
Why?
Hemorrhagic Disorders
1
1988
5
0.040
Why?
Acetylcysteine
1
2008
81
0.040
Why?
Prostatectomy
1
2009
84
0.040
Why?
Retinoid X Receptor beta
1
2008
5
0.040
Why?
Retinoid X Receptor alpha
1
2008
7
0.040
Why?
Pulmonary Fibrosis
1
1989
139
0.040
Why?
Thiazolidines
1
2008
11
0.040
Why?
Arteriovenous Malformations
1
1988
11
0.040
Why?
Europe
1
2008
77
0.040
Why?
Bicyclo Compounds, Heterocyclic
1
2008
14
0.040
Why?
Infusions, Intra-Arterial
2
1984
14
0.040
Why?
Factor XIII Deficiency
1
1987
1
0.040
Why?
Sequence Homology, Nucleic Acid
1
1988
144
0.040
Why?
Radiation Injuries, Experimental
1
2008
89
0.040
Why?
Platelet Count
1
1987
52
0.040
Why?
Gastrointestinal Hemorrhage
1
1988
87
0.040
Why?
Pilot Projects
1
2009
446
0.040
Why?
Protein Isoforms
1
2008
115
0.040
Why?
Prosthesis Fitting
1
2007
12
0.040
Why?
Dimerization
1
2008
167
0.040
Why?
Albumins
2
1997
54
0.040
Why?
Overweight
1
2007
42
0.040
Why?
Endothelium
1
1987
60
0.040
Why?
Graft Occlusion, Vascular
1
2007
25
0.040
Why?
Cross-Over Studies
1
2007
119
0.040
Why?
Prosthesis Design
1
2007
64
0.040
Why?
Flow Cytometry
1
2009
603
0.040
Why?
Immunodiffusion
2
1982
43
0.040
Why?
Glutathione
1
2008
231
0.040
Why?
International Cooperation
1
1987
71
0.040
Why?
Antioxidants
1
2008
201
0.040
Why?
Bone Marrow Transplantation
1
1987
201
0.040
Why?
Mortality
1
2007
91
0.030
Why?
Population Surveillance
1
2007
144
0.030
Why?
Collagen
1
2008
301
0.030
Why?
Iatrogenic Disease
1
1986
28
0.030
Why?
Immunoglobulin M
2
1989
150
0.030
Why?
Monocytes
1
2008
317
0.030
Why?
Mice, Knockout
1
2009
922
0.030
Why?
Immunohistochemistry
1
2009
1082
0.030
Why?
Liver Diseases
1
1985
80
0.030
Why?
Sex Distribution
1
2005
161
0.030
Why?
Alanine Transaminase
1
2005
24
0.030
Why?
Ligands
1
2006
294
0.030
Why?
Age Distribution
1
2005
227
0.030
Why?
Homeostasis
1
1986
177
0.030
Why?
Genetic Testing
1
2005
102
0.030
Why?
Leukemia
1
2006
158
0.030
Why?
Kidney Transplantation
1
1986
176
0.030
Why?
Lymphoma
1
2006
163
0.030
Why?
bcl-Associated Death Protein
1
2004
5
0.030
Why?
Ristocetin
2
1980
6
0.030
Why?
Aorta, Abdominal
1
1984
17
0.030
Why?
Aortic Aneurysm
1
1984
20
0.030
Why?
bcl-2-Associated X Protein
1
2004
55
0.030
Why?
Autoradiography
2
1979
131
0.030
Why?
Kidney Diseases
1
1986
170
0.030
Why?
Chromatography, Gel
2
1980
113
0.030
Why?
Proportional Hazards Models
1
2005
426
0.030
Why?
Chromatography, Affinity
1
1984
92
0.030
Why?
Wheat Germ Agglutinins
1
1983
16
0.030
Why?
Mice, Inbred C57BL
1
2009
1700
0.030
Why?
Caspase 9
1
2003
15
0.030
Why?
Insulin
1
2007
670
0.030
Why?
Caspase 8
1
2003
7
0.030
Why?
Particle Size
1
2004
203
0.030
Why?
Immunoglobulin G
2
1989
494
0.030
Why?
Lipoproteins
1
2004
98
0.030
Why?
Cell Differentiation
1
2009
1127
0.030
Why?
Chemical Precipitation
2
1979
28
0.030
Why?
Complement Inactivator Proteins
1
2003
14
0.030
Why?
Models, Cardiovascular
2
1993
68
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2004
116
0.030
Why?
Poly(ADP-ribose) Polymerases
1
2003
59
0.030
Why?
Hip
1
1983
12
0.030
Why?
Biopsy
1
2004
384
0.030
Why?
Vena Cava Filters
1
2003
10
0.030
Why?
Knee
1
1983
23
0.030
Why?
Intraoperative Care
1
1983
30
0.030
Why?
Bone Marrow Cells
1
2004
222
0.030
Why?
Peripheral Vascular Diseases
1
2003
27
0.030
Why?
Caspases
1
2003
105
0.030
Why?
Coronary Circulation
3
1985
93
0.030
Why?
Regression Analysis
1
2004
539
0.030
Why?
Fibronectins
1
1983
151
0.030
Why?
Adenosine Triphosphate
1
2004
415
0.030
Why?
Proto-Oncogene Proteins
1
2004
301
0.030
Why?
Endopeptidases
1
1981
59
0.020
Why?
Convalescence
1
2001
17
0.020
Why?
Serum Amyloid A Protein
1
2001
22
0.020
Why?
Matched-Pair Analysis
1
2001
15
0.020
Why?
Referral and Consultation
1
2003
207
0.020
Why?
beta 2-Glycoprotein I
1
2000
4
0.020
Why?
Outpatients
1
2000
31
0.020
Why?
Solubility
1
1980
114
0.020
Why?
Macrophages
1
1982
347
0.020
Why?
Canada
1
2000
77
0.020
Why?
Interleukin-6
1
2003
339
0.020
Why?
Frail Elderly
1
2001
60
0.020
Why?
Carrier Proteins
1
2004
446
0.020
Why?
Models, Molecular
1
1982
366
0.020
Why?
Inhalation
1
1999
14
0.020
Why?
Bronchoscopy
1
1999
30
0.020
Why?
DNA-Binding Proteins
1
2004
691
0.020
Why?
Factor VIII
1
1980
107
0.020
Why?
Least-Squares Analysis
1
1998
29
0.020
Why?
Microspheres
1
1998
56
0.020
Why?
Acoustics
1
1998
37
0.020
Why?
Injections, Intra-Arterial
2
1985
31
0.020
Why?
Linear Models
1
1998
248
0.020
Why?
Edetic Acid
1
1996
64
0.020
Why?
Epitope Mapping
1
1996
29
0.020
Why?
Mice, Inbred C3H
1
1997
237
0.020
Why?
Mice, Inbred Strains
1
1997
247
0.020
Why?
Bronchial Diseases
1
1995
8
0.020
Why?
Pleural Diseases
1
1995
13
0.020
Why?
Pleura
1
1995
18
0.020
Why?
Tissue Adhesions
1
1995
40
0.020
Why?
Child
2
1986
4342
0.020
Why?
Models, Structural
1
1994
53
0.020
Why?
Amputation
1
1994
24
0.020
Why?
Calibration
1
1994
44
0.020
Why?
Reference Standards
1
1994
45
0.020
Why?
Blood Proteins
1
1994
95
0.010
Why?
Temperature
1
1994
247
0.010
Why?
Infant
1
1999
2320
0.010
Why?
Intraoperative Complications
1
1993
61
0.010
Why?
Preventive Medicine
1
1993
39
0.010
Why?
Sequence Homology, Amino Acid
1
1993
293
0.010
Why?
Lung Diseases
1
1995
224
0.010
Why?
Research Support as Topic
1
1993
55
0.010
Why?
Substrate Specificity
1
1993
247
0.010
Why?
Child, Preschool
1
1999
2737
0.010
Why?
Guidelines as Topic
1
1993
91
0.010
Why?
Thermodynamics
1
1993
240
0.010
Why?
Cost-Benefit Analysis
1
1993
215
0.010
Why?
Cerebrovascular Disorders
1
1992
114
0.010
Why?
Reference Values
1
1992
453
0.010
Why?
Hemoglobins
1
1990
95
0.010
Why?
Smoking
1
1995
423
0.010
Why?
Quality of Health Care
1
1993
230
0.010
Why?
Epirubicin
1
1989
2
0.010
Why?
Immunoglobulin A
1
1989
88
0.010
Why?
Methylprednisolone
1
1989
46
0.010
Why?
Respiratory Function Tests
1
1989
129
0.010
Why?
Organ Specificity
1
1989
165
0.010
Why?
Fluorescent Antibody Technique
1
1989
307
0.010
Why?
Carboplatin
1
1989
29
0.010
Why?
Etoposide
1
1989
83
0.010
Why?
Doxorubicin
1
1989
105
0.010
Why?
Protein Processing, Post-Translational
1
1989
141
0.010
Why?
Bronchoalveolar Lavage Fluid
1
1989
301
0.010
Why?
Vincristine
1
1987
61
0.010
Why?
Remission Induction
1
1988
165
0.010
Why?
Methotrexate
1
1987
73
0.010
Why?
Transplantation, Autologous
1
1987
151
0.010
Why?
Cyclophosphamide
1
1987
177
0.010
Why?
Neoplasm Staging
1
1989
354
0.010
Why?
Bleeding Time
1
1987
9
0.010
Why?
Hirudins
1
1987
8
0.010
Why?
Blood Protein Electrophoresis
1
1986
31
0.010
Why?
Latex Fixation Tests
1
1986
21
0.010
Why?
Protamines
1
1986
18
0.010
Why?
False Positive Reactions
1
1986
88
0.010
Why?
Hemagglutination Inhibition Tests
1
1986
74
0.010
Why?
Adenosine Diphosphate
1
1986
97
0.010
Why?
Graft Rejection
1
1986
144
0.010
Why?
Neoplasm Recurrence, Local
1
1987
295
0.010
Why?
Angiography
1
1985
91
0.010
Why?
Lidocaine
1
1985
76
0.010
Why?
Colony-Stimulating Factors
1
1982
27
0.010
Why?
Protein Subunits
1
1983
100
0.010
Why?
Monokines
1
1982
40
0.010
Why?
Subcellular Fractions
1
1982
99
0.010
Why?
Erythropoiesis
1
1982
63
0.010
Why?
Phosphorylation
1
1984
839
0.010
Why?
Disulfides
1
1981
26
0.010
Why?
Cryoglobulins
1
1980
25
0.010
Why?
Freezing
1
1980
32
0.010
Why?
Chemical Phenomena
1
1980
68
0.010
Why?
Protein Precursors
1
1981
84
0.010
Why?
Densitometry
1
1980
35
0.010
Why?
Chemistry
1
1980
69
0.010
Why?
Proteins
1
1982
470
0.010
Why?

Visualizations


Francis's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department